| Unconventional strategy could be the future: From target to KRAS broad range treatment S Fancelli, G Petroni, S Pillozzi, L Antonuzzo Heliyon 10 (9), 2024 | 1 | 2024 |
| Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy G Petroni, S Pillozzi, L Antonuzzo Cancer Research 84 (8), 1199-1209, 2024 | 1 | 2024 |
| Cellular senescence and aging G Petroni, O Kepp, L Galluzzi (No Title), 2024 | | 2024 |
| Cellular senescence and aging at the crossroad between immunity and cancer O Kepp, L Galluzzi, G Petroni Methods in cell biology 181, xvii-xxiv, 2024 | | 2024 |
| 36P Expression of germinal center B cell-and Th17 cell-related transcripts are prognostic of soft-tissue sarcoma patient outcomes G Petroni, F Scolari, E Caliman, R Scanferla, G Scoccianti, A Palomba, ... Immuno-Oncology and Technology 20, 2023 | | 2023 |
| Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients D Lavacchi, S Gelmini, A Calabri, G Rossi, L Simi, E Caliman, I Mancini, ... Heliyon 9 (11), 2023 | 1 | 2023 |
| Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors. V Klapp, N Bloy, C Jiménez-Cortegana, A Buqué, G Petroni Methods in Cell Biology 181, 197-212, 2023 | | 2023 |
| Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors V Klapp, A Buqué, N Bloy, A Sato, T Yamazaki, XK Zhou, SC Formenti, ... Journal of Translational Medicine 21 (1), 110, 2023 | 4 | 2023 |
| Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence V Klapp, N Bloy, G Petroni, M De Martino Methods in Cell Biology 174, 113-126, 2023 | 1 | 2023 |
| Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification E Caliman, S Fancelli, G Petroni, MRG Michelet, F Cosso, C Ottanelli, ... Lung Cancer 175, 88-100, 2023 | 13 | 2023 |
| 446 HR+ breast cancer: defining innate and acquired resistance to immune Checkpoint inhibitors AB Martinez, N Bloy, M Hensler, G Petroni, A Sato, T Yamazaki, B Bhinder, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| 1144 IL17-producing γδ T cells promote resistance to CDK4/6 inhibitors in HR+ HER2-breast cancer G Petroni, K Gouin, C Galassi, A Buqué, N Bloy, T Yamazaki, A Sato, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Anticancer effects of PARP1 hyperactivation by a decoy oligodeoxynucleotide in vitro and in vivo. W Jdey, C Doizelet, C Galassi, C Zandanel, V Trochon-Joseph, V Hayes, ... Journal of Clinical Oncology 40 (16_suppl), e15060-e15060, 2022 | | 2022 |
| Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment G Petroni, A Buqué, LM Coussens, L Galluzzi Nature reviews Drug discovery 21 (6), 440-462, 2022 | 66 | 2022 |
| Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer G Petroni, LC Cantley, L Santambrogio, SC Formenti, L Galluzzi Nature Reviews Clinical Oncology 19 (2), 114-131, 2022 | 99 | 2022 |
| Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis A Sato, N Bloy, C Galassi, C Jiménez-Cortegana, V Klapp, A Aretz, ... Methods in Cell Biology 172, 115-134, 2022 | | 2022 |
| RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells C Galassi, Y Ruan, A Sato, C Jiménez-Cortegana, V Klapp, N Bloy, ... Methods in Cell Biology 172, 145-161, 2022 | | 2022 |
| Cytofluorometric assessment of cell cycle progression in irradiated cells C Jiménez-Cortegana, V Klapp, N Bloy, C Galassi, A Sato, T Yamazaki, ... Methods in Cell Biology 172, 1-16, 2022 | 2 | 2022 |
| 733 Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer G Petroni, K Gouin, AB Martinez, S Knott, S Formenti, L Galluzzi Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A763-A763, 2021 | | 2021 |
| 285 Breaking through the resistance of breast cancer to immune checkpoint blockers in a unique mouse model of HR+ disease N Bloy, AB Martinez, B Binder, G Petroni, T Yamazaki, A Sato, O Elemento, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
